Deutsche Bank Ag\ Pardes Biosciences, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.4 - $1.95 $28,092 - $39,128	-20,066 Reduced 99.27%	147 $0
Q1 2023 May 15, 2023	BUY	$1.21 - $2.22 $10,254 - $18,814	8,475 Added 72.2%	20,213 $26,000
Q4 2022 Feb 13, 2023	BUY	$0.85 - $1.69 $195 - $388	230 Added 2.0%	11,738 $19,000
Q3 2022 Nov 14, 2022	SELL	$2.14 - $3.7 $4,042 - $6,989	-1,889 Reduced 14.1%	11,508 $21,000
Q2 2022 Aug 11, 2022	BUY	$2.84 - $8.57 $38,047 - $114,812	13,397 New	13,397 $41,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.